{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:01:54Z","timestamp":1792677714352,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010248","name":"Zhejiang Province Public Welfare Technology Application Research Project","doi-asserted-by":"publisher","award":["LGF18H160014"],"award-info":[{"award-number":["LGF18H160014"]}],"id":[{"id":"10.13039\/501100010248","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013091","name":"Science and Technology Major Project of Guangxi","doi-asserted-by":"publisher","award":["2017ZX10204401"],"award-info":[{"award-number":["2017ZX10204401"]}],"id":[{"id":"10.13039\/501100013091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.hbpd.2020.05.009","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T19:00:11Z","timestamp":1591124411000},"page":"384-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China"],"prefix":"10.1016","volume":"19","author":[{"given":"Xin","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Feng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2020.05.009_bib0001","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cld.728","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"12","author":"Terrault","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0003","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0004","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/S0140-6736(18)31865-8","article-title":"Chronic hepatitis B virus infection","volume":"392","author":"Seto","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0006","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0007","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/liv.13536","article-title":"Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection","volume":"37","author":"Cao","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0008","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4137\/BMI.S10009","article-title":"Molecular serum markers of liver fibrosis","volume":"7","author":"Liu","year":"2012","journal-title":"Biomark Insights"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0009","first-page":"862","article-title":"Correlation of laparoscopic liver biopsy to elasticity measurements (FibroScan) in patients with chronic liver disease","volume":"4","author":"Nudo","year":"2008","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gut.2008.156489","article-title":"Elastography for the non-invasive assessment of liver disease: limitations and future developments","volume":"58","author":"Vizzutti","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0011","doi-asserted-by":"crossref","first-page":"18131","DOI":"10.3748\/wjg.v20.i48.18131","article-title":"Non invasive tools for the diagnosis of liver cirrhosis","volume":"20","author":"Soresi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0012","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0013","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0014","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Cast\u00e9ra","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0015","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ajg.2011.100","article-title":"A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C","volume":"106","author":"Boursier","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0016","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1478-3231.2009.02192.x","article-title":"Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients","volume":"30","author":"Kim","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0017","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-2036.2010.04276.x","article-title":"Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B","volume":"31","author":"Wong","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0018","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/10408360802334743","article-title":"Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics","volume":"45","author":"Coffman","year":"2008","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0019","doi-asserted-by":"crossref","first-page":"9922","DOI":"10.3390\/ijms16059922","article-title":"Quantitative real-time PCR analysis of YKL-40 and its comparison with mammalian chitinase mRNAs in normal human tissues using a single standard DNA","volume":"16","author":"Ohno","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/omi.2015.0037","article-title":"CHI3L1 is a liver-enriched, noninvasive biomarker that can be used to stage and diagnose substantial hepatic fibrosis","volume":"19","author":"Huang","year":"2015","journal-title":"OMICS"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0021","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1089-3261(02)00009-0","article-title":"Scoring of chronic hepatitis","volume":"6","author":"Scheuer","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0022","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3350\/cmh.2014.20.3.228","article-title":"Prediction of fibrosis progression in chronic viral hepatitis","volume":"20","author":"Wong","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0023","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/geno.1997.4778","article-title":"Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation","volume":"43","author":"Rehli","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0024","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/cancers2031453","article-title":"YKL-40-A protein in the field of translational medicine: a role as a biomarker in cancer patients?","volume":"2","author":"Schultz","year":"2010","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0025","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0168-8278(00)80095-1","article-title":"Serum YKL-40 is increased in patients with hepatic fibrosis","volume":"32","author":"Johansen","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0026","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1590\/S0100-879X2012007500010","article-title":"Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension","volume":"45","author":"Wang","year":"2012","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0027","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s15010-018-1136-2","article-title":"Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT","volume":"46","author":"Yan","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0028","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/gut.2010.207423","article-title":"Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C","volume":"59","author":"Fontana","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0029","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/00042737-200012090-00004","article-title":"Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease","volume":"12","author":"Tran","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0030","series-title":"Screening of significant liver fibrosis in general populations and high risk HBV carriers in China","author":"Wu","year":"2018"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0031","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3343\/alm.2018.38.4.348","article-title":"Diagnosis of liver fibrosis with Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA-M2BP) among chronic hepatitis B patients","volume":"38","author":"Jekarl","year":"2018","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0032","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/gut.2005.065136","article-title":"Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications","volume":"54","author":"Yuen","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0033","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1440-1746.2009.05953.x","article-title":"Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B","volume":"25","author":"Lee","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0034","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2018.04.036","article-title":"The combination of 5 serum markers compared to FibroScan to predict significant liver fibrosis in patients with chronic hepatitis B virus","volume":"483","author":"Dong","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12967-018-1462-2","article-title":"Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B","volume":"16","author":"Wu","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0036","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/bj20020075","article-title":"The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways","volume":"365","author":"Recklies","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0037","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.hbpd.2018.04.003","article-title":"Hepatic fibrosis: it is time to go with hepatic stellate cell-specific therapeutic targets","volume":"17","author":"Ezhilarasan","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0038","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.celrep.2013.07.032","article-title":"Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor \u03b12","volume":"4","author":"He","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0039","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2011.11.016","article-title":"Twenty-year protocol liver biopsies: invasive but useful for the management of liver recipients","volume":"56","author":"Sebagh","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2008.09.016","article-title":"A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection","volume":"50","author":"Berres","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2020.05.009_bib0041","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.cgh.2007.07.020","article-title":"Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis","volume":"5","author":"Talwalkar","year":"2007","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387220301144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387220301144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:40:51Z","timestamp":1761493251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387220301144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1499387220301144"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2020.05.009","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2020.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}